ArticleCurrent reviews in clinical and experimental pharmacology2022

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.

Tomohito Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.